Biosimilars
Biosimilars/Peptides

Aflibercept
Form: Vial
THERAPEUTIC AREA: Ophtalmology

Adalimumab
Form: PFS/AI
THERAPEUTIC AREA: Rheumatology

BV-GLP1-01
Form: PFS
THERAPEUTIC AREA: Diabetes

Denosumab
Form: PFS
THERAPEUTIC AREA: Rheumatology

Denosumab
Form: PFS
THERAPEUTIC AREA: Rheumatology

Dupilumab
Form: PFS/AI
THERAPEUTIC AREA: Dermatology / Immunology

Golimumab
Form: PFS/AI
THERAPEUTIC AREA: Rheumatology

Guselkumab
Form: PFS/AI
THERAPEUTIC AREA: Dermatology / Immunology

Ixekizumab
Form: PFS/AI
THERAPEUTIC AREA: Dermatology / Immunology

Liraglutide
Form: AI (Prefilled Pen)
THERAPEUTIC AREA: Diabetes

Omalizumab
Form: Vial/PFS
THERAPEUTIC AREA: Respiratory

Pembrolizumab
Form: Vial/Lyo Powder
THERAPEUTIC AREA: Oncology

Teriparatide
Form: AI (Pen)
THERAPEUTIC AREA: Rheumatology

Ustekinumab
Form: Vial
THERAPEUTIC AREA: Dermatology / Immunology

Vedolizumab
Form: Lyo Powder
THERAPEUTIC AREA: Gastroenterology
GlobalOne Healthcare Holding
In addition to licensing, the organization is committed to expanding market presence and contract manufacturing for operating companies across the Middle East, Africa, and beyond. This can facilitate the distribution of important healthcare products to regions where they may not be readily available, improving access to care and promoting better health outcomes. Through its commercial partners, the organization can also leverage local knowledge and expertise to navigate the complexities of these markets and ensure the successful introduction of new products.
Finally, the organization recognizes the importance of investing in late-stage biotech and health/medtech startups to expand its healthcare portfolio globally. By supporting the development of promising new products and technologies, the organization can contribute to the advancement of healthcare and improve outcomes for patients around the world. These investments can also generate returns for the organization and its partners, helping to fund future innovation and growth. Overall, the organization’s mandate reflects a commitment to driving innovation, improving access to care, and promoting better health outcomes for all.